Arkolith/Insider Trading/TYRA/Form 4

Bensen Daniel

Chief Discovery OfficerTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Jan 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$228K
Net Open-Market Flow
-$228K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 12, 2026Sell(S)7K$28.44$199K156K
Jan 12, 2026Sell(S)1K$29.08$30K155K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-016651) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML